Related Experiment Video
Updated: Jan 21, 2026

Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
Distinct effects of etoposide on glutamine-addicted neuroblastoma
Kadri Valter1, Polina Maximchik2, Alibek Abdrakhmanov2
1Division of Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Box 210, 171 77, Stockholm, Sweden.
Abstract:
The majority of anticancer drugs are DNA-damaging agents, and whether or not they may directly target mitochondria remains unclear. In addition, tumors such as neuroblastoma exhibit addiction to glutamine in spite of it being a nonessential amino acid. Our aim was to evaluate the direct effect of widely used anticancer drugs on mitochondrial activity in combination with glutamine withdrawal, and possible apoptotic effects of such interaction. Our results revealed that etoposide inhibits mitochondrial respiratory chain Complex I causing the leakage of electrons and the superoxide radical formation. However, it was not sufficient to induce apoptosis, and apoptotic manifestation was detectable only alongside the withdrawal of glutamine, a precursor for antioxidant glutathione. Thus, the simultaneous depletion of glutathione and destabilization of mitochondria by ROS can compromise the barrier properties of the mitochondrial membrane, leading to cytochrome c release and the activation of the mitochondrial apoptotic pathway. Thus, the depletion of antioxidants or the inhibition of the pathways responsible for cellular antioxidant response can enhance mitochondrial targeting and strengthen antitumor therapy.
Insights
Anticancer drugs like etoposide can destabilize mitochondria and, when combined with glutamine withdrawal, induce cancer cell death. Depleting antioxidants enhances this mitochondrial-targeted cancer therapy.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Most anticancer drugs damage DNA; their direct impact on mitochondria is unclear.
- Tumors like neuroblastoma often depend on glutamine, a nonessential amino acid.
Purpose of the Study:
- To investigate the direct effects of common anticancer drugs on mitochondrial activity.
- To assess the impact of combining these drugs with glutamine withdrawal on cancer cell apoptosis.
Main Methods:
- Treatment of cancer cells with etoposide.
- Glutamine withdrawal experiments.
- Assessment of mitochondrial activity, reactive oxygen species (ROS) production, and apoptosis.
Main Results:
- Etoposide inhibits mitochondrial Complex I, increasing superoxide radical formation.
- Etoposide alone did not induce apoptosis.
- Apoptosis was observed only when glutamine withdrawal depleted glutathione (an antioxidant).
- Combined etoposide and glutamine withdrawal destabilized mitochondria, releasing cytochrome c and activating apoptosis.
Conclusions:
- Simultaneous glutathione depletion and mitochondrial destabilization by ROS trigger the mitochondrial apoptotic pathway.
- Inhibiting cellular antioxidant responses can enhance mitochondrial targeting for stronger antitumor therapy.
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Framing Effects
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Biological Effects of Radiation
Self-Awareness and Its Effects

